Wogonin inhibits multiple myeloma-stimulated angiogenesis via c-Myc/VHL/HIF-1a signaling axis

被引:30
作者
Fu, Rong [1 ,2 ]
Chen, Yan [1 ,2 ]
Wang, Xiao-Ping [1 ,2 ]
An, Teng [1 ,2 ]
Tao, Lei [1 ,2 ]
Zhou, Yu-Xin [1 ,2 ]
Huang, Yu-Jie [1 ,2 ]
Chen, Bao-An [3 ]
Li, Zhi-Yu [4 ]
You, Qi-Dong [5 ]
Guo, Qing-Long [1 ,2 ]
Wu, Zhao-Qiu [1 ,2 ]
机构
[1] China Pharmaceut Univ, State Key Lab Nat Med, Dept Physiol, Nanjing 210009, Jiangsu, Peoples R China
[2] China Pharmaceut Univ, Jiangsu Key Lab Carcinogenesis & Intervent, Nanjing 210009, Jiangsu, Peoples R China
[3] Southeast Univ, Sch Med, Zhongda Hosp, Dept Hematol & Oncol, Nanjing 211189, Jiangsu, Peoples R China
[4] China Pharmaceut Univ, Dept Med Chem, Nanjing 210009, Jiangsu, Peoples R China
[5] China Pharmaceut Univ, Jiangsu Key Lab Drug Design & Optimizat, Nanjing 210009, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
wogonin; angiogenesis; VHL; c-Myc; multiple myeloma; BONE-MARROW MICROENVIRONMENT; GENE-EXPRESSION; CELLS; HIF-1-ALPHA; GROWTH; IDENTIFICATION; PROTEIN; BLOCKS; TARGET;
D O I
10.18632/oncotarget.6796
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Angiogenesis is associated with the progression of multiple myeloma (MM). Wogonin is an active mono-flavonoid with remarkable antitumor activity. However, its impact on MM-stimulated angiogenesis remains largely unknown. Here, we demonstrated that wogonin decreased expression and secretion of pro-angiogenic factors in MM cells via c-Myc/HIF-1a signaling axis, reducing MM-stimulated angiogenesis and MM cell proliferation in vivo. Overexpression of c-Myc in MM cells disrupted the balance between VHL SUMOylation and ubiquitination, and thus inhibited proteasome-mediated HIF-1a degradation. Impaired function of VHL ubiquitination complex in c-Myc-overexpressing cells was fully reversed by wogonin treatment via increasing HIF-1a-VHL interaction and promoting HIF-1a degradation. Collectively, our in vitro and in vivo studies reveal for the first time that wogonin represses MM-stimulated angiogenesis and tumor progression via c-Myc/VHL/HIF-1a signaling axis.
引用
收藏
页码:5715 / 5727
页数:13
相关论文
共 27 条
  • [1] Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma
    Affer, M.
    Chesi, M.
    Chen, W. D.
    Keats, J. J.
    Demchenko, Y. N.
    Tamizhmani, K.
    Garbitt, V. M.
    Riggs, D. L.
    Brents, L. A.
    Roschke, A. V.
    Van Wier, S.
    Fonseca, R.
    Bergsagel, P. L.
    Kuehl, W. M.
    [J]. LEUKEMIA, 2014, 28 (08) : 1725 - 1735
  • [2] Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLCγ1- and Ca2+-dependent apoptosis
    Baumann, Sven
    Fas, Stefanie C.
    Giaisi, Marco
    Mueller, Wolfgang W.
    Merling, Anette
    Guelow, Karsten
    Edler, Lutz
    Krammer, Peter H.
    Li-Weber, Min
    [J]. BLOOD, 2008, 111 (04) : 2354 - 2363
  • [3] Curcurnin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells
    Bharti, AC
    Donato, N
    Aggarwal, BB
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 171 (07) : 3863 - 3871
  • [4] Angiopoietins as biomarker of disease activity and response to therapy in multiple myeloma
    Bhaskar, Archana
    Gupta, Ritu
    Vishnubhatla, Sreenivas
    Kumar, Lalit
    Sharma, Atul
    Sharma, Mehar Chand
    Das, Prasenjit
    Thakur, Sonu Chand
    [J]. LEUKEMIA & LYMPHOMA, 2013, 54 (07) : 1473 - 1478
  • [5] Therapeutic targeting of hypoxia and hypoxia-inducible factor 1 alpha in multiple myeloma
    Borsi, Enrica
    Terragna, Carolina
    Brioli, Annamaria
    Tacchetti, Paola
    Martell, Marina
    Cavo, Michele
    [J]. TRANSLATIONAL RESEARCH, 2015, 165 (06) : 641 - 650
  • [6] HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironment
    Borsi, Enrica
    Perrone, Giulia
    Terragna, Carolina
    Martello, Marina
    Zamagni, Elena
    Tacchetti, Paola
    Pantani, Lucia
    Brioli, Annamaria
    Dico, Angela Flores
    Zannetti, Beatrice Anna
    Rocchi, Serena
    Cavo, Michele
    [J]. EXPERIMENTAL CELL RESEARCH, 2014, 328 (02) : 444 - 455
  • [7] Hypoxia inducible factor-1 alpha as a therapeutic target in multiple myeloma
    Borsi, Enrica
    Perrone, Giulia
    Terragna, Carolina
    Martello, Marina
    Dico, Angela F.
    Solaini, Giancarlo
    Baracca, Alessandra
    Sgarbi, Gianluca
    Pasquinelli, Gianandrea
    Valente, Sabrina
    Zamagni, Elena
    Tacchetti, Paola
    Martinelli, Giovanni
    Cavo, Michele
    [J]. ONCOTARGET, 2014, 5 (07) : 1779 - 1792
  • [8] Hypoxia Inactivates the VHL Tumor Suppressor through PIASy-Mediated SUMO Modification
    Cai, Qiliang
    Verma, Suhbash C.
    Kumar, Pankaj
    Ma, Michelle
    Robertson, Erle S.
    [J]. PLOS ONE, 2010, 5 (03):
  • [9] Associations of VEGF and VEGFR2 polymorphisms with increased risk and aggressiveness of multiple myeloma
    Carvalho Brito, Angelo Borsarelli
    Lourenco, Gustavo Jacob
    Oliveira, Gislaine Borba
    De Souza, Carmino Antonio
    Vassallo, Jose
    Passos Lima, Carmen Silvia
    [J]. ANNALS OF HEMATOLOGY, 2014, 93 (08) : 1363 - 1369
  • [10] Myc Posttranscriptionally Induces HIF1 Protein and Target Gene Expression in Normal and Cancer Cells
    Doe, Megan R.
    Ascano, Janice M.
    Kaur, Mandeep
    Cole, Michael D.
    [J]. CANCER RESEARCH, 2012, 72 (04) : 949 - 957